About Cellebration Life Sciences
Cellebration Life Sciences is a company based in San Diego (United States) founded in 2019 by Tim Kopatich and Anand Srivastava.. Cellebration Life Sciences has raised $3.09 million across 2 funding rounds. Cellebration Life Sciences operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
- Headquarter San Diego, United States
- Founders Tim Kopatich, Anand Srivastava
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.09 M (USD)
in 2 rounds
-
Latest Funding Round
$2.8 M (USD), Seed
Aug 01, 2023
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Cellebration Life Sciences
Cellebration Life Sciences has successfully raised a total of $3.09M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2.8 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $2.8M
-
First Round
First Round
(02 Jun 2021)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Seed - Cellebration Life Sciences | Valuation |
investors |
|
| Jun, 2021 | Amount | Seed - Cellebration Life Sciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Cellebration Life Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cellebration Life Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cellebration Life Sciences Comparisons
Competitors of Cellebration Life Sciences
Cellebration Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery and development services for small molecules are provided.
|
|
| domain | founded_year | HQ Location |
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| domain | founded_year | HQ Location |
Generic drugs and clinical research services are provided globally.
|
|
| domain | founded_year | HQ Location |
Laboratory testing, clinical trial research, and biopharma services are provided.
|
|
| domain | founded_year | HQ Location |
Novel point-of-care testing and low-dose interferon therapeutics are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cellebration Life Sciences
Frequently Asked Questions about Cellebration Life Sciences
When was Cellebration Life Sciences founded?
Cellebration Life Sciences was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Where is Cellebration Life Sciences located?
Cellebration Life Sciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Cellebration Life Sciences?
Tim Kopatich is the current CEO of Cellebration Life Sciences. They have also founded this company.
Is Cellebration Life Sciences a funded company?
Cellebration Life Sciences is a funded company, having raised a total of $3.09M across 2 funding rounds to date. The company's 1st funding round was a Seed of $285K, raised on Jun 02, 2021.
What does Cellebration Life Sciences do?
Cellebration Life Sciences was established in 2019 in San Diego, United States. Research, development, and manufacturing services for biologic drugs are offered within the biotechnology sector. Operations are centered on supporting pharmaceutical needs through these capabilities. The company is led by co-founders Tim Kopatich as CEO and Anand Srivastava as Chairman. Its online presence is maintained via cellebrationlifesciences.com.